Research use only
Not for human consumption, veterinary use, or clinical administration. Sold exclusively to qualified laboratories and researchers for in-vitro study.
Metabolic
Retatrutide
Retatrutide is an investigational synthetic peptide designed as a triple agonist of the GIP, GLP-1 and glucagon receptors. It is being evaluated in controlled clinical research for its effects on metabolic signalling. Retatrutide has not been approved by any regulatory authority, and its safety and efficacy outside clinical trials are not established. For qualified analytical and in-vitro research only — not for human or veterinary use, consumption or injection.